TREACE JOHN T. (Chief Executive Officer) purchased 0.7% of their position (50K shares) of TREACE MEDICAL CONCEPTS, INC. on the open market
Open‑market purchase worth $177.9K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/1/2026ACC: 0001193125-26-251587
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2021
+50K
Net shares
Net buyer
$177.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
$3.56
Trade value
$177.91K
% of position
0.7%
6/1/2026
7.27M→7.32M
Total
Net shares
+50K
Net value
$177.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | P · Purchase | +50K | $3.56 | $177.91K | 0.7% | 7.27M | 7.32M |
| Total | +50K | $177.91K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned1.60M
Common Stock
IndirectShares owned1.84M
Common Stock
IndirectShares owned1.47M
Common Stock
IndirectShares owned408.82K
Total
5.32M indirect5.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.60M | Indirect |
| Common Stock | 1.84M | Indirect |
| Common Stock | 1.47M | Indirect |
| Common Stock | 408.82K | Indirect |
| Total | 5.32M | 5.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported